Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus - PubMed (original) (raw)
Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus
S M Richardson-Burns et al. Biol Psychiatry. 2000.
Abstract
Background: The central role that the thalamus plays in information processing and sensory integration suggests that its dysfunction may be a factor in the pathophysiology of schizophrenia. Glutamate is a key neurotransmitter in thalamic function, and although all aspects of thalamic glutamate neurotransmission have not been elucidated, transcripts encoding members of each family of the glutamate receptors have been identified in the thalamus. Recently, activation of group II metabotropic glutamate receptors (mGluRs) was demonstrated in rats to ameliorate the behavioral effects associated with exposure to phencyclidine, an uncompetitive NMDA receptor antagonist that can induce psychotic symptoms, suggesting the possibility of mGluR abnormalities in schizophrenia. We investigated whether expression of thalamic mGluR mRNA is altered in this illness.
Methods: We examined the expression of the transcripts encoding the mGluR1, 2, 3, 4, 5, 7, and 8 receptors in postmortem thalamic tissue samples from elderly schizophrenic and control subjects, using in situ hybridization. We identified six thalamic nuclei in each section (anterior, dorsomedial, lateral dorsal, central medial, reticular, and nuclei of the ventral tier).
Results: There were no differences between elderly schizophrenic and control subjects in the expression of mGluR1, 2, 3, 4, 5, 7, or 8 transcript levels in any of these six thalamic nuclei.
Conclusions: mGluR mRNA expression is not abnormal in the thalamus of patients with schizophrenia. The modulatory roles proposed for mGluRs, and the potentially important relationship between mGluRs and NMDA receptors, suggest that mGluRs may be involved in the pathophysiology of schizophrenia, but this is not detectable at this level of gene expression.
Similar articles
- Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.
Ibrahim HM, Hogg AJ Jr, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH. Ibrahim HM, et al. Am J Psychiatry. 2000 Nov;157(11):1811-23. doi: 10.1176/appi.ajp.157.11.1811. Am J Psychiatry. 2000. PMID: 11058479 - Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Smith RE, et al. Am J Psychiatry. 2001 Sep;158(9):1393-9. doi: 10.1176/appi.ajp.158.9.1393. Am J Psychiatry. 2001. PMID: 11532723 - Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat.
Lourenço Neto F, Schadrack J, Berthele A, Zieglgänsberger W, Tölle TR, Castro-Lopes JM. Lourenço Neto F, et al. Brain Res. 2000 Jan 31;854(1-2):93-105. doi: 10.1016/s0006-8993(99)02326-4. Brain Res. 2000. PMID: 10784111 - The role of group I metabotropic glutamate receptors in schizophrenia.
Pietraszek M, Nagel J, Gravius A, Schäfer D, Danysz W. Pietraszek M, et al. Amino Acids. 2007 Feb;32(2):173-8. doi: 10.1007/s00726-006-0319-9. Epub 2006 May 15. Amino Acids. 2007. PMID: 16699816 Review. - [Chemical anatomy of the thalamus in the schizophrenia].
Giménez Amaya JM. Giménez Amaya JM. An R Acad Nac Med (Madr). 2008;125(1):179-91; discussion 191-2. An R Acad Nac Med (Madr). 2008. PMID: 18777850 Review. Spanish.
Cited by
- Glycine Transporter 1 Inhibitors: Predictions on Their Possible Mechanisms in the Development of Opioid Analgesic Tolerance.
Galambos AR, Papp ZT, Boldizsár I, Zádor F, Köles L, Harsing LG Jr, Al-Khrasani M. Galambos AR, et al. Biomedicines. 2024 Feb 12;12(2):421. doi: 10.3390/biomedicines12020421. Biomedicines. 2024. PMID: 38398023 Free PMC article. Review. - Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.
Cieślik P, Wierońska JM. Cieślik P, et al. Int J Mol Sci. 2020 Nov 20;21(22):8811. doi: 10.3390/ijms21228811. Int J Mol Sci. 2020. PMID: 33233865 Free PMC article. Review. - Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs.
Muguruza C, Meana JJ, Callado LF. Muguruza C, et al. Front Pharmacol. 2016 May 20;7:130. doi: 10.3389/fphar.2016.00130. eCollection 2016. Front Pharmacol. 2016. PMID: 27242534 Free PMC article. Review. - Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.
García-Bea A, Walker MA, Hyde TM, Kleinman JE, Harrison PJ, Lane TA. García-Bea A, et al. Schizophr Res. 2016 Nov;177(1-3):18-27. doi: 10.1016/j.schres.2016.04.015. Epub 2016 Apr 27. Schizophr Res. 2016. PMID: 27130562 Free PMC article. - Metabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging.
Pillai RL, Tipre DN. Pillai RL, et al. Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1151-70. doi: 10.1007/s00259-015-3301-5. Epub 2016 Jan 7. Eur J Nucl Med Mol Imaging. 2016. PMID: 26743895 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical